Webinar: Keeping the OPTIONs open for the treatment of diabetic peripheral neuropathic pain

Keeping the OPTIONs open for the treatment of diabetic peripheral neuropathic pain
Thursday 4th May 2023, 5:00pm - 6:00pm

In the second of the 2023 ABCD webinar series, please join Dr. Kevin Fernando to discuss ‘Keeping the OPTIONs open for the treatment of diabetic peripheral neuropathic pain’ including a summary of the OPTION-DM trial.

Diabetic peripheral neuropathic pain (DPNP) is a frequent complication of diabetes and a major cause of morbidity and reduction in quality of life. Despite this, there is little comparative evidence on which analgesic treatment to recommend or whether they should be combined. The aim of the OPTION-DM trial was to establish the most clinically beneficial and best tolerated treatment pathway for people with DPNP.  This session will cover key take-home messages from OPTION-DM as well practical tips & pitfalls to avoid for the treatment of peripheral & autonomic neuropathy

Q& A will follow this presentation.

RCP Accreditation has been sought for this webinar. Certificates of attendance will be issued to those who attend the live webinar.

This webinar has been instigated and organised by ABCD. The support from our corporate sponsors has allowed us to provide this valuable educational meeting free of charge to all delegates. Sponsors have had no input into the agenda or the selection of speakers.

 

Register Now

Speakers

  • Dr. Sarah Brewster

    SpR

    Coming soon ..

  • Dr. Kevin Fernando

    Coming soon ..

  • Professor Gerry Rayman

    image of Professor Gerry Rayman

    Gerry Rayman is a Consultant Physician at the Diabetes and Endocrine Centre, Ipswich Hospitals NHS Trust, Hon Professor at University of East Anglia, Visiting Professor at the University of Suffolk and Associate Lecturer at Cambridge University. He has developed a nationally renowned Diabetes Centre and Diabetes Foot Clinic. He contributes to research into complications of diabetes, particularly foot complications, new technologies in diabetes care including devices and diabetes education. He has been the clinical lead for DiabetesUK’s ‘Putting Feet First’ campaign and has contributed to NICE guidelines on the diabetic foot (CG10, CG119 NG 19) and the NCEPOD recommendations on lower limb amputations and perioperative care. He has been the NHS Diabetes Clinical lead for diabetes in-patient care and foot disease. He is the innovator and lead of the National Diabetes Inpatient Audit. He is the immediate past President of the Endocrine and Diabetes Section of the Royal Society of Medicine, Chair of DiabetesUK’s Clinical Study Group in Acute Care and the GIRFT lead for Diabetes.